Skip to main contentSkip to navigationSkip to search
HNSA (, %) SEK
Hansa Biopharma logotype
EN,SE

Contacts

Investor Relations Contact

Klaus Sindahl

Head of Investor Relations

Mobile: +46 (0) 709 298 269

Email: klaus.sindahl@hansabiopharma.com

Corporate Communications Contact

Katja Margell

Head of Corporate Communications 

Mobile: +46 (0) 768 198 326

Email: katja.margell@hansabiopharma.com